Robyn Moxon has over 10 years of experience supporting Alzheimer’s Disease research. She joined Acumen as the Manager of Corporate and Clinical Communications in 2022. In this role, she is tasked with overseeing all aspects of Acumen’s communications strategy and execution, including corporate branding, public relations, social media initiatives, and clinical trial recruitment. Robyn has an extensive background in developing successful communications programs in the medical technology space. Prior to Acumen she worked at Functional Neuromodulation where she led communications efforts focused on media relations, corporate reputation, social media campaigns and clinical trial recruitment for a global Phase 3 Alzheimer’s study. She also worked with the clinical team to facilitate study activities, manage vendors, maintain clinical documents and oversaw regulatory and IRB submissions. Robyn holds an MA in Communications from Bethel University in St. Paul, MN.